Trial intelligence / Profile preview

Interfascial blockade of trapezius muscle with bupivacaine in fibromyalgia

2015-000796-28Phase 4Active

Sponsor
Fundació Clínic per a la Recerca Biomèdica
Start
Jun 2015
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, single-blind trial in fibromyalgia (FM) and myalgia comparing Bupivacaine arm with Placebo arm (2 arms). Primary endpoint: Regional pain VAS at the trapezius muscle. Started Jun 2015; status: active.

02

Drugs

bupivacaine
03

Conditions

fibromyalgia (FM)myalgia

Beyond the preview

Go deeper on 2015-000796-28.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2015-000796-28.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call